Canine Cancer Osteosarcoma Research
In our relentless pursuit of advancements in veterinary oncology, the FidoCure Team’s research has taken center stage, offering an in-depth exploration into the realm of canine osteosarcoma. The use of real-world data and machine learning techniques promises to provide invaluable insights into the mutation patterns and treatment outcomes associated with this challenging condition.
Mammary Carcinoma: Insights from BRCA1 mutations
Genetic Signatures in Canine Mammary Tumors: insights from BRCA1 mutations
Innovative Bioinformatics Pipeline Reduces Costs and Expands Access to Precision Therapeutics for Canine Oncology
Today we would like to share another exciting development in the field of canine oncology genetics and precision therapeutics from our manuscript “Shared Hotspot Mutations in Oncogenes Position Dogs as an Unparalleled Comparative Model for Precision Therapeutics,” recently published in Scientific Reports.
Cancer Does Not Have to Be a Death Sentence
FidoCure® Precision Medicine Data Showcased at the American Association of Cancer Research (AACR)
At the AACR 2023 annual meeting, Dr. Lucas Rodrigues, Head of Veterinary Research at FidoCure®, presented the results of two innovative studies which demonstrated the power of real-world data from dogs with cancer to drive drug development strategies and inform human clinical trials. The first study, titled “High frequency of TP53 mutations in canine skin […]